Veterinary and Comparative Oncology

Papers
(The TQCC of Veterinary and Comparative Oncology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
High lysyl oxidase expression is an indicator of poor prognosis in dogs with cutaneous mast cell tumours23
Timely adjuvant chemotherapy improves outcome in dogs with non‐metastatic splenic hemangiosarcoma undergoing splenectomy22
Issue Information21
Serum thymidine kinase 1 activity as a prognostic biomarker in dogs with chemotherapy‐treated diffuse large B‐cell lymphoma19
Treatment of feline intermediate to high‐grade alimentary lymphoma: A retrospective evaluation of 55 cats treated with the VAPC combination chemotherapy protocol (2017–2021)19
Ultrasound‐guided core needle biopsy in dogs with thyroid carcinoma18
Effects of a high‐protein, increased‐fibre, dry diet supplemented with omega‐3 fatty acids on quality of life in dogs undergoing chemotherapy18
Investigation of efficacy of two different chemotherapy protocols used in neoadjuvant chemotherapy in clinical stages II–IV canine malignant mammary tumours17
Outcomes of 35 dogs with craniomaxillofacial osteosarcoma treated with stereotactic body radiation therapy15
Standardisation of canine meningioma grading: Inter‐observer agreement and recommendations for reproducible histopathologic criteria13
Dysregulated miRNAs in a canine model of haemangiosarcoma metastatic to the brain13
Combining radiation therapy with zoledronate for the treatment of osteo‐invasive feline oral squamous cell carcinoma13
Plasma cell‐free DNA in canine lymphoma patients as a novel material for genotyping13
Pre‐operative neoadjuvant vinblastine‐prednisolone in canine mast cell tumours: A single‐centre retrospective cohort study13
Descriptive analysis of haemangiosarcoma occurrence in dogs enrolled in the Golden Retriever lifetime study12
Risk factors associated with the onset of lomustine‐induced neutropenia in tumour‐bearing dogs12
Outcome of dogs treated with chemotherapy for mesothelioma: A retrospective clinical study on 40 cases and a literature review11
Blood biomarkers for canine cancer, from human to veterinary oncology11
Polarisation Sensitive Optical Coherence Tomography Image Characteristics for Gastrointestinal Tumours and Normal Tissues at Surgical Margins in Dogs11
Chronic adrenergic stress and generation of myeloid‐derived suppressor cells: Implications for cancer immunotherapy in dogs11
Cover Image10
Issue Information10
Issue Information10
Efficacy and toxicity of carboplatin in the treatment of macroscopic mesenchymal neoplasia in dogs9
Issue Information9
Prognostic Value of a Histopathological Scoring System and the Ki67 Proliferation Index in Dogs With Phaeochromocytoma9
9
Corrigendum9
Effects of Lipophilic Statins on Cell Viability and Tissue Factor Expression in Canine Haemangiosarcoma Cells8
Author Index8
8
Use of Cystourethroscopy to Define the Gross Tumour Volume in Radiation Treatment Planning for Canine Genitourinary Carcinomas8
8
Expression of Concern: Tumour necrosis factor‐alpha‐induced protein 8 (TNFAIP8) expression associated with cell survival and death in cancer cell lines infected with canine distemper virus8
Immunophenotyping and Mutation Analysis of Canine Intestinal T‐Cell Lymphoma: A Comparative Pathological Study of Human Enteropathy‐Associated T‐Cell Lymphoma8
Extensive staging has no prognostic value in dogs with low‐risk mast cell tumours8
Frontal sinus carcinoma in forty‐one dogs (2001–2022)7
Issue Information7
Spotlight on capecitabine for the treatment of unresectable or metastatic carcinoma of various origin: A retrospective study of 25 dogs7
7
Epidemiology of canine cutaneous round cell tumours on the canary archipelago in Spain7
Issue Information7
Classification and Prognostication of B‐Cell and T‐Cell Multicentric Lymphoma in Dogs Using Serum MicroRNAs7
Fractionated oral dosing and its effect on cyclophosphamide pharmacokinetics in dogs with high‐grade multicentric lymphoma7
Issue Information6
DNA Methylation and Its Effects on TRIM29 Gene Expression in the Equine Sarcoid Tissue6
Serum Lactate Dehydrogenase as a Potential Prognostic Biomarker in Dogs With Appendicular Osteosarcoma6
Quantification of circulating tumour cells over time in dogs with appendicular osteosarcoma6
Issue Information6
Outcome in dogs with curative‐intent treatment of localized primary pulmonary histiocytic sarcoma6
Use of Lomustine and Prednisolone as First‐Line Treatment in Canine Multicentric Lymphoma6
Blood Neutrophil‐to‐Lymphocyte Ratio as a Potential Prognostic Marker in Dogs ≤10 kg With Multicentric Lymphoma6
Author Index6
6
6
Defining the relevance of surgical margins. Part two: Strategies to improve prediction of recurrence risk6
Retrospective analysis of outcome and prognostic factors of subcutaneous mast cell tumours in dogs undergoing surgery with or without adjuvant treatment5
Vinorelbine as a Rescue Treatment for Canine Histiocytic Sarcoma: A Multicentre Retrospective Study of 18 Dogs5
Sodium iodide symporter immunolabelling as a predictor of clinical iodide uptake in canine thyroid carcinoma: A preliminary study5
5
Impact of 10% Dose Reductions and Duration of Treatment Delays in the Management of Chemotherapy‐Induced Neutropenia in Dogs Treated With Common Chemotherapy Protocols: A Single‐Centre Experience5
Comparison of the anticancer effects of various statins on canine oral melanoma cells5
Configuration of pathologic fractures in dogs with osteosarcoma following stereotactic body radiation therapy: A retrospective analysis5
Molecular Classification Based on the Gene Expression Profiles in Canine Histiocytic Sarcoma Cells5
Evaluation of serum interleukin 2 receptor and beta‐2‐microglobulin as prognostic factors for canine lymphoma: A pilot study5
Evaluation of the anti‐tumour activity of Coriolus versicolor polysaccharopeptide (I'm‐Yunity) alone or in combination with doxorubicin for canine splenic hemangiosarcoma5
Isolation of Tumour‐Derived Extracellular Vesicles From the Plasma of Dogs Affected by Intracranial Tumours Showing Heterologous and Cross‐Species Tropism: A Pilot Study5
Overactivation of Signal Transducer and Activator of Transcription 3 in Canine Hepatocellular Carcinoma and Its Prognostic Significance5
5
Evaluation of the health‐related quality of life in dogs following intracranial meningioma resection using a specifically developed questionnaire5
Description and efficacy of a response‐based “QUAD” cyclical hypofractionated palliative‐intent radiation protocol in dogs with macroscopic solid tumours: 108 cases5
Favourable Prognostic Significance of HER2 Mutations in Canine Pulmonary Adenocarcinoma Following Surgical Resection5
Correction to “DNA Methylation and Its Effects on TRIM29 Gene Expression in the Equine Sarcoid Tissue”4
Half‐Body Radiation Therapy Results in a Prolonged Progression‐Free Interval in Canine High‐Grade Lymphoma After First Remission4
Mass spectrometric‐based assessment of the serum kappa to lambda immunoglobulin light chain ratio (κ:λ) in dogs with immunoglobulin secretory diseases4
Sentinel lymph node mapping in canine mast cell tumours using a preoperative radiographic indirect lymphography: Technique description and results in 138 cases4
4
Sentinel lymph node mapping with computed tomography lymphography for mast cell tumours and a comparison between regional and sentinel lymph node histological status: Sixty‐two cases4
Evaluating the relevance of surgical margins. Part one: The problems with current methodology4
Developing a translational murine‐to‐canine pathway for anIL‐2/agonistanti‐CD40antibody cancer immunotherapy4
Identification of potential plasma protein biomarkers for feline pancreatic carcinoma by liquid chromatography tandem mass spectrometry4
Stereotactic body radiation therapy as an alternative to adrenalectomy for the treatment of pheochromocytomas in 8 dogs4
Cyclical 10‐day dosing of melphalan for canine multiple myeloma4
Are severe adverse events commonly observed in dogs during cancer chemotherapy? A retrospective study on 155 dogs4
VCS abstract4
Ovariectomy reduces the risk of tumour development and influences the histologic continuum in canine mammary tumours4
The role of toceranib phosphate in dogs with non‐mast cell neoplasia: A systematic review4
Clinical Response to Imatinib Mesylate and Toxicity Profile in 35 Dogs With Mast Cell Tumours4
Correlation between computed tomography and histological evaluation of nodal metastasis in dogs with mast cell tumours4
Newcastle disease virus LaSota strain induces apoptosis and activates the TNFα/NF‐κB pathway in canine mammary carcinoma cells4
Immunological Pre‐Metastatic Niche in Dogs With Naturally Occurring Osteosarcoma4
2.7584700584412